Abstract:STUDY QUESTION How do NR4A receptors drive decidualization of human endometrial stromal cells (hESCs)? SUMMARY ANSWER NR4A receptors modulate endometrial decidualization by transcriptional activation of FOXO1A, and in adenomyosis patients, the reduced expression of NR4A receptors in the eutopic endometrium may represent a novel mechanism to explain impaired decidualization and subfertility. WHAT IS KNOWN ALREADY A close relationship between impaired decidualization and subfertility has been established. In human endometrial stromal cells, orphan nuclear receptor NR4A is a novel regulator of decidualization. STUDY DESIGN, SAMPLES/MATERIALS, METHODS Eutopic endometrial tissues and hESCs from fertile controls (n = 56) and adenomyosis patients (n = 27) were collected for in vitro analysis. Primary hESCs isolated from eutopic endometrial tissues were used to evaluate the biological function of NR4A receptors. Adenovirus-mediated overexpression of NR4A and small interfering RNAs targeting NR4A, and FOXO1A were used to investigate the molecular mechanisms. Gene expression regulation was examined by real-time-quantitative PCR, immunostaining, and luciferase reporter assay. Artificial decidualization assay was performed to investigate the role of NR4A1 during decidualization in vivo. MAIN RESULTS AND THE ROLE OF CHANCE NR4A modulates the decidualization of hESCs by upregulating prolactin (PRL) and insulin-like growth factor binding protein-1 (IGFBP-1) expression and transformation in vitro. Loss of uterine Nr4a1 results in female subfertility due to impaired decidualization. Mechanistically, NR4A binds to the nerve growth factor 1B (NGFI-B) -responsive element (NBRE) (-843 to -813) within the FOXO1A promoter region and regulates FOXO1A expression. Loss of FOXO1A significantly inhibits PRL and IGFBP-1 expression, as induced by NR4A. Moreover, the expression of NR4A and FOXO1A was lower in adenomyosis endometrial tissues compared to fertile controls, especially in stroma compartments. Ectopic NR4A expression rescued PRL and IGFBP-1 expression in adenomyotic hESCs to near-normal levels. Furthermore, PI3K/AKT signaling pathway involved in inducing NR4A expression under decidualization stimuli in hESCs and the level of p(Ser473)-AKT was significantly higher in stroma in endometrium from patients with adenomyosis. LIMITATIONS, REASONS FOR CAUTION This is an in vitro study with a small sample size, utilizing stromal cell cultures from endometrial tissues of adenomyosis patients. Furthermore, results obtained should also be confirmed in a larger data set and with adenomyosis mouse models in vivo. WIDER IMPLICATIONS OF THE FINDINGS Identification of a positive agonist of NR4A receptors will be critical for the improved treatment of patients with conditions of insufficient decidualization-associated infertility, such as adenomyosis and endometriosis. LARGE SCALE DATA N/A. STUDY FUNDING AND COMPETING INTERESTS This study was supported by the National Natural Science Foundation of China (81170570, G.J.Y. 81370683, G.J.Y. 81501251, Y.J. 31571189, H.X.S. and 81571402, G.J.Y.), and a special grant for clinical medicine science of Jiangsu Province (BL2014003, H.X.S.). The authors have no conflicts of interest to declare.

Adenosine Deaminase Family Acting on RNA 1 ( ADAR1 ) May Be a De Novo Target for Endometriosis Treatment

Adenosine Deaminase Acting on RNA 1 (ADAR1) As Crucial Regulators in Cardiovascular Diseases: Structures, Pathogenesis, and Potential Therapeutic Approach

Increased endometrial expression of CC-chemokine receptor-1 in women with adenomyosis.

The adenosine deaminase family acting on RNA 1 can be a useful diagnostic biomarker in chorioamnionitis

ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer

Loss of ADAR1 induces ferroptosis of breast cancer cells

The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways

The role of RNA editing enzyme ADAR1 in human disease

High-throughput virtual screening to identify potential small molecule inhibitors of the Zα domain of the adenosine deaminases acting on RNA 1(ADAR1)

Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes

Abstract 2767: Exploring ADAR1 dependencies in breast cancer brain-metastases

Abstract 1332: Adar1 impacts pancreatic homeostasis and pancreatic tumor biology

Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis

Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance

Decreased Expression of NR4A Nuclear Receptors in Adenomyosis Impairs Endometrial Decidualization.

Adiponectin receptor 1 regulates endometrial receptivity via the adenosine monophosphate‐activated protein kinase/E‐cadherin pathway

P3489Endothelial adenosine-to-inosine RNA editing is indispensable for vascular integrity

Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous

Adenosine Deaminases Acting on RNA, RNA Editing, and Interferon Action

Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis

Abstract 341: Study Of ADAR1 Implicates RNA Editing In Vascular Smooth Muscle Cells As A Mechanism Of Coronary Artery Disease Risk